These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37011768)

  • 1. Design, synthesis, structure-activity relationship studies, and evaluation of novel GLS1 inhibitors.
    Jo M; Koizumi K; Suzuki M; Kanayama D; Watanabe Y; Gouda H; Mori H; Mizuguchi M; Obita T; Nabeshima Y; Toyooka N; Okada T
    Bioorg Med Chem Lett; 2023 May; 87():129266. PubMed ID: 37011768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of novel glutaminase 1 allosteric inhibitors with an alkane chain tail group.
    Chang X; Wang M; Zhang D; Zhang Y; Wang J; Li Z; Bian J; Xu X
    Eur J Med Chem; 2023 Jan; 246():115014. PubMed ID: 36525694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site.
    Xu X; Wang J; Wang M; Yuan X; Li L; Zhang C; Huang H; Jing T; Wang C; Tong C; Zhou L; Meng Y; Xu P; Kou J; Qiu Z; Li Z; Bian J
    J Med Chem; 2021 Apr; 64(8):4588-4611. PubMed ID: 33792311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and pharmacological evaluation of 2-(1-(1,3,4-thiadiazol-2-yl)piperidin-4-yl)ethan-1-ol analogs as novel glutaminase 1 inhibitors.
    Yang T; Tian Y; Yang Y; Tang M; Shi M; Chen Y; Yang Z; Chen L
    Eur J Med Chem; 2022 Dec; 243():114686. PubMed ID: 36055003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
    Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY
    Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based virtual screening discovers novel kidney-type glutaminase inhibitors.
    Lin LC; Chang HY; Lin TE; Lin JR; Hsia SM; Hsu KC; Huang TC
    Biomed Pharmacother; 2022 Oct; 154():113585. PubMed ID: 36029536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.
    Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W
    Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel glutaminase 1 allosteric inhibitor with 4-piperidinamine linker and aromatic heterocycles.
    Xu X; Chang X; Huang J; Zhang D; Wang M; Jing T; Zhuang Y; Kou J; Qiu Z; Wang J; Li Z; Bian J
    Eur J Med Chem; 2022 Jun; 236():114337. PubMed ID: 35428013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors.
    Yeh TK; Kuo CC; Lee YZ; Ke YY; Chu KF; Hsu HY; Chang HY; Liu YW; Song JS; Yang CW; Lin LM; Sun M; Wu SH; Kuo PC; Shih C; Chen CT; Tsou LK; Lee SJ
    J Med Chem; 2017 Jul; 60(13):5599-5612. PubMed ID: 28609101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An updated patent review of glutaminase inhibitors (2019-2022).
    Wang D; Li X; Gong G; Lu Y; Guo Z; Chen R; Huang H; Li Z; Bian J
    Expert Opin Ther Pat; 2023 Jan; 33(1):17-28. PubMed ID: 36698323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity.
    Okada T; Yamabe K; Jo M; Sakajiri Y; Shibata T; Sawada R; Yamanishi Y; Kanayama D; Mori H; Mizuguchi M; Obita T; Nabeshima Y; Koizumi K; Toyooka N
    Bioorg Med Chem Lett; 2023 Sep; 93():129438. PubMed ID: 37549852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis.
    Zhang C; Liu J; Zhao Y; Yue X; Zhu Y; Wang X; Wu H; Blanco F; Li S; Bhanot G; Haffty BG; Hu W; Feng Z
    Elife; 2016 Jan; 5():e10727. PubMed ID: 26751560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
    Jacque N; Ronchetti AM; Larrue C; Meunier G; Birsen R; Willems L; Saland E; Decroocq J; Maciel TT; Lambert M; Poulain L; Hospital MA; Sujobert P; Joseph L; Chapuis N; Lacombe C; Moura IC; Demo S; Sarry JE; Recher C; Mayeux P; Tamburini J; Bouscary D
    Blood; 2015 Sep; 126(11):1346-56. PubMed ID: 26186940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic importance of the glutaminase II pathway in normal and cancerous cells.
    Dorai T; Pinto JT; Denton TT; Krasnikov BF; Cooper AJL
    Anal Biochem; 2022 May; 644():114083. PubMed ID: 33352190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Glutaminase Inhibitor Compound 968 Exhibits Potent
    Guo H; Li W; Pan G; Wang C; Li D; Liu N; Sheng X; Yuan L
    Anticancer Agents Med Chem; 2023; 23(2):210-221. PubMed ID: 35570522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLS1 is a protective factor in patients with ovarian clear cell carcinoma and its expression does not correlate with ARID1A-mutated tumors.
    Clemente V; Hoshino A; Shetty M; Nelson A; Erickson BK; Baker R; Rubin N; Khalifa M; Weroha SJ; Lou E; Bazzaro M
    Cancer Res Commun; 2022 Aug; 2(8):784-794. PubMed ID: 36082022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics.
    Chen Y; Tan L; Gao J; Lin C; Wu F; Li Y; Zhang J
    Eur J Med Chem; 2023 Apr; 252():115306. PubMed ID: 36996714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain slices from glutaminase-deficient mice metabolize less glutamine: a cellular metabolomic study with carbon 13 NMR.
    El Hage M; Masson J; Conjard-Duplany A; Ferrier B; Baverel G; Martin G
    J Cereb Blood Flow Metab; 2012 May; 32(5):816-24. PubMed ID: 22373647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma.
    Yu D; Shi X; Meng G; Chen J; Yan C; Jiang Y; Wei J; Ding Y
    Oncotarget; 2015 Apr; 6(10):7619-31. PubMed ID: 25844758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis.
    Takahashi S; Saegusa J; Sendo S; Okano T; Akashi K; Irino Y; Morinobu A
    Arthritis Res Ther; 2017 Apr; 19(1):76. PubMed ID: 28399896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.